We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
280 hedge funds and large institutions have $8.69B invested in Alnylam Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 107 increasing their positions, 79 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
42% more call options, than puts
Call options by funds: $113M | Put options by funds: $79.5M
38% more funds holding in top 10
Funds holding in top 10: 8 → 11 (+3)
35% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 79
13% more capital invested
Capital invested by funds: $7.7B → $8.69B (+$995M)
2.41% less ownership
Funds ownership: 99.59% → 97.18% (-2.4%)
3% less funds holding
Funds holding: 290 → 280 (-10)
23% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 44
Holders
280
Holders Change
-10
Holders Change %
-3.45%
% of All Funds
6.14%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.24%
New
34
Increased
107
Reduced
79
Closed
44
Calls
$113M
Puts
$79.5M
Net Calls
+$33.5M
Net Calls Change
+$14.6M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$160M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$109M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$66.9M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$55.4M |
| 5 |
BlackRock
New York
|
+$44.9M |
Top Sellers
| 1 |
MC
Maverick Capital
Dallas,
Texas
|
-$80.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$70.1M |
| 3 |
RI
RTW Investments
New York
|
-$34.1M |
| 4 |
HM
HealthCor Management
New York
|
-$34M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$28.9M |
